A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

The primary study objective was to evaluate the prognostic value of post-therapeutic SPECT by RECIP 1.0 for overall survival.

The primary endpoint is objective response rate, with progression-free survival a key secondary endpoint. The study includes a pre-registration step for arm determination by the molecular tumor board.

External beam radiation therapy with or without short-term androgen deprivation showed 15-year survival benefits for ...

With a new treatment for prostate cancer in play, men with more aggressive forms of prostate cancer may have a more positive ...

NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with a market capitalization of $17.4 billion, has announced results from its Phase 3 TALAPRO-2 study which show that a combination of ...

Iowa has one of the highest cancer rates in the country, and alarming new data shows an increased cancer risk for Black men. Prostate cancer is the second-leading cause of cancer death in American men ...

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...